Article
The role of clinical response to metformin in patients newly diagnosed with type 2 diabetes: a monotherapy study.
Clinical and experimental medicine - 1 May 2015
Mahrooz Abdolkarim, Parsanasab Hassan, Hashemi-Soteh Mohammad Bagher, Kashi Zahra, Bahar Adele, Alizadeh Ahad, Mozayeni Maliheh
Abstract excerpt
A major predicament in certain users of metformin, which is one of the most commonly used antihyperglycemic agents for type 2 diabetes (T2DM) treatment, is the lack of appropriate response to the drug. We evaluated the role of metformin response and OCT1 (organic cation transporter1) Met420del polymorphism in a monotherapy study (metformin therapy for 12 weeks) on patients newly diagnosed with T2DM. Based on the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
